Tabaton M - Search Results

1

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.

Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezzini P, Bertolini S, Mann DM, Tabaton M, Gambetti P. Teller JK, et al. Among authors: tabaton m. Nat Med. 1996 Jan;2(1):93-5. doi: 10.1038/nm0196-93. Nat Med. 1996. PMID: 8564851

2

Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains.

Russo C, Saido TC, DeBusk LM, Tabaton M, Gambetti P, Teller JK. Russo C, et al. Among authors: tabaton m. FEBS Lett. 1997 Jun 16;409(3):411-6. doi: 10.1016/s0014-5793(97)00564-4. FEBS Lett. 1997. PMID: 9224700 Free article.

3

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

Russo C, Angelini G, Dapino D, Piccini A, Piombo G, Schettini G, Chen S, Teller JK, Zaccheo D, Gambetti P, Tabaton M. Russo C, et al. Among authors: tabaton m. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15598-602. doi: 10.1073/pnas.95.26.15598. Proc Natl Acad Sci U S A. 1998. PMID: 9861015 Free PMC article.

4

Presenilin-1 mutations in Alzheimer's disease.

Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B, Gambetti P, Tabaton M, Teller JK. Russo C, et al. Among authors: tabaton m. Nature. 2000 Jun 1;405(6786):531-2. doi: 10.1038/35014735. Nature. 2000. PMID: 10850703 No abstract available.

5

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Tabaton M, et al. Biochem Biophys Res Commun. 1994 May 16;200(3):1598-603. doi: 10.1006/bbrc.1994.1634. Biochem Biophys Res Commun. 1994. PMID: 8185615

6

Soluble amyloid-beta in the brain: the scarlet pimpernel.

Tabaton M, Gambetti P. Tabaton M, et al. J Alzheimers Dis. 2006;9(3 Suppl):127-32. doi: 10.3233/jad-2006-9s315. J Alzheimers Dis. 2006. PMID: 16914851 Review.

7

Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities.

Tabaton M, Cammarata S, Mandybur T, Richey P, Kawai M, Perry G, Gambetti P. Tabaton M, et al. Brain Res. 1992 Oct 16;593(2):299-303. doi: 10.1016/0006-8993(92)91323-7. Brain Res. 1992. PMID: 1280524

8

Plasma levels of amyloid beta 40 and 42 are independent from ApoE genotype and mental retardation in Down syndrome.

Cavani S, Tamaoka A, Moretti A, Marinelli L, Angelini G, Di Stefano S, Piombo G, Cazzulo V, Matsuno S, Shoji S, Furiya Y, Zaccheo D, Dagna-Bricarelli F, Tabaton M, Mori H. Cavani S, et al. Among authors: tabaton m. Am J Med Genet. 2000 Nov 27;95(3):224-8. Am J Med Genet. 2000. PMID: 11102927

9

The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.

Autilio-Gambetti L, Morandi A, Tabaton M, Schaetzle B, Kovacs D, Perry G, Sharma S, Cornette J, Greenberg B, Gambetti P. Autilio-Gambetti L, et al. Among authors: tabaton m. FEBS Lett. 1988 Dec 5;241(1-2):94-8. doi: 10.1016/0014-5793(88)81038-x. FEBS Lett. 1988. PMID: 2904381 Free article.

10

Is amyloid beta-protein glycated in Alzheimer's disease?

Tabaton M, Perry G, Smith M, Vitek M, Angelini G, Dapino D, Garibaldi S, Zaccheo D, Odetti P. Tabaton M, et al. Neuroreport. 1997 Mar 3;8(4):907-9. doi: 10.1097/00001756-199703030-00018. Neuroreport. 1997. PMID: 9141062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page